Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-04-18 00:00:00 ET · period of report 2023-04-17 · accession 0001209191-23-024725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-18 | 2023-04-17 | VKTX | MACARTNEY LAWSON | Dir | M - OptEx | $8.00 | +20.8K | 68.8K | +43% | +$166.3K |
| D | 2023-04-18 | 2023-04-17 | VKTX | MACARTNEY LAWSON | Dir | S - Sale+OE | $20.00 | -20.8K | 48.0K | -30% | -$415.7K |
| D | 2023-04-18 | 2023-04-17 | VKTX | MACARTNEY LAWSON | Dir | M - OptEx | $0.00 | -20.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2023-04-17 | M | A | 20,786 | $8.00 | 68,751 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2023-04-17 | S | D | 20,786 | $20.00 | 47,965 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-04-17 | M | D | 20,786 | $0.00 | 0 | D | $8.00 · 2016-05-26 to 2025-04-28 | 20,786 Common Stock | (F2) 100% of the shares subject to the option vested on May 26, 2016, the date of the Issuer's first Annual Meeting of Stockholders following the date of grant. |